Back
SOPHiA GENETICS SA 10K Form
Buy
64
SOPH
SOPHiA GENETICS SA
Last Price:
$5.07
Seasonality Move:
-18.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SOPH News And Ratings
See the #1 stock for the next 7 days that we like better than SOPH
SOPH Financial Statistics
Sales & Book Value
| Annual Sales: | $77.3M |
|---|---|
| Cash Flow: | $-11.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.69 |
| Price / Book: | 7.63 |
Profitability
| EPS (TTM): | -1.16940 |
|---|---|
| Net Income (TTM): | $-79M |
| Gross Margin: | $47.8M |
| Return on Equity: | -107.74% |
| Return on Assets: | -48.91% |
SOPHiA GENETICS SA Earnings Forecast
Key SOPHiA GENETICS SA Financial Ratios
-
The Gross Profit Margin over the past 7 years for SOPH is 61.88%.
-
The Selling, General & Administrative Expenses for SOPH have been equal to 114.77% of Gross Profit Margin.
-
The Research & Development expenses have been 43.44% of Revenue.
-
The Net Earning history of SOPH is -102.24% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
SOPHiA GENETICS SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | SOPH |
| Website: | sophiagenetics.com |
Debt
| Debt-to-Equity Ratio: | 1.34 |
|---|---|
| Current Ratio: | 1.96 |
| Quick Ratio: | 1.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SOPH Technical Analysis vs Fundamental Analysis
Buy
64
SOPHiA GENETICS SA (SOPH)
is a Buy
Is SOPHiA GENETICS SA a Buy or a Sell?
-
SOPHiA GENETICS SA stock is rated a BuyThe current SOPHiA GENETICS SA [SOPH] share price is $5.04. The Score for SOPH is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.